PELLEGATA, NATALIA SIMONA
PELLEGATA, NATALIA SIMONA
DIPARTIMENTO DI BIOLOGIA E BIOTECNOLOGIE "LAZZARO SPALLANZANI"
A 5'-truncated c-myc gene variant not associated with a risk of cancer
1991-01-01 Pellegata, Ns; Bergamaschi, G; Amadori, D; Aloia, A; Ballarini, P; Del Senno, L; Amaducci, L; Ranzani, Guglielmina
Adipocyte-specific tribbles pseudokinase 1 regulates plasma adiponectin and plasma lipids in mice
2022-01-01 Ha, E. E.; Quartuccia, G. I.; Ling, R.; Xue, C.; Karikari, R. A.; Hernandez-Ono, A.; Hu, K. Y.; Matias, C. V.; Imam, R.; Cui, J.; Pellegata, N. S.; Herzig, S.; Georgiadi, A.; Soni, R. K.; Bauer, R. C.
Adiponectin affects the mechanical responses in strips from the mouse gastric fundus
2018-01-01 Idrizaj, E.; Garella, R.; Castellini, G.; Mohr, H.; Pellegata, N. S.; Francini, F.; Ricca, V.; Squecco, R.; Baccari, M. C.
Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients
2019-01-01 Daly, A. F.; Rostomyan, L.; Betea, D.; Bonneville, J. -F.; Villa, C.; Pellegata, N. S.; Waser, B.; Reubi, J. -C.; Stephan, C. W.; Christ, E.; Beckers, A.
Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix
1995-01-01 Tenti, P; Romagnoli, S; Silini, E; Pellegata, Ns; Zappatore, Rita; Spinillo, Arsenio; Zara, Carlo; Ranzani, Guglielmina; Carnevali, Luciano
Angpt2/Tie2 autostimulatory loop controls tumorigenesis
2022-01-01 Karabid, N. M.; Wiedemann, T.; Gulde, S.; Mohr, H.; Segaran, R. C.; Geppert, J.; Rohm, M.; Vitale, G.; Gaudenzi, G.; Dicitore, A.; Ankerst, D. P.; Chen, Y.; Braren, R.; Kaissis, G.; Schilling, F.; Schillmaier, M.; Eisenhofer, G.; Herzig, S.; Roncaroli, F.; Honegger, J. B.; Pellegata, N. S.
Animal models of MEN1
2017-01-01 Mohr, H.; Pellegata, N. S.
Animal models of multiple endocrine neoplasia
2016-01-01 Wiedemann, T.; Pellegata, N. S.
Base transitions are the most frequent genetic changes at P53 in gastric cancer
1993-01-01 Renault, B; van den Broek, M; Fodde, R; Wijnen, J; Pellegata, Ns; Amadori, D; Khan, Pm; Ranzani, Guglielmina
CDKN1B (p27) defects leading to pituitary tumors
2021-01-01 Pellegata, Natalia S.
Characterization of neuroendocrine tumors in heterozygous mutant MENX rats: A novel model of invasive medullary thyroid carcinoma
2018-01-01 Molatore, S.; Kugler, A.; Irmler, M.; Wiedemann, T.; Neff, F.; Feuchtinger, A.; Beckers, J.; Robledo, M.; Roncaroli, F.; Pellegata, N. S.
Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects
2022-01-01 Gulde, Sebastian; Foscarini, Alessia; April-Monn, Simon L.; Genio, Edoardo; Marangelo, Alessandro; Satam, Swapna; Helbling, Daniel; Falconi, Massimo; Toledo, Rodrigo A.; Schrader, Jörg; Perren, Aurel; Marinoni, Ilaria; Pellegata, Natalia S.
Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer
1992-01-01 Pellegata, Ns; Losekoot, M; Fodde, R; Pugliese, V; Saccomanno, S; Renault, B; Bernini, Lf; Ranzani, Guglielmina
Editorial: Stem Cells in Endocrine Tumors
2021-01-01 Di Franco, S.; Pellegata, N. S.; Luconi, M.; Stassi, G.
Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions
2001-01-01 Scovassi, Al; Pellegata, Ns; Di Stefano, L; Padovan, L; Negri, C; Prosperi, Ennio; Riva, Federica; Ciomei, M; Ranzani, Guglielmina
Gender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumors
2021-01-01 Gulde, S.; Wiedemann, T.; Schillmaier, M.; Valenca, I.; Lupp, A.; Steiger, K.; Yen, H. -Y.; Bauerle, S.; Notni, J.; Luque, R.; Schmid, H.; Schulz, S.; Ankerst, D. P.; Schilling, F.; Pellegata, N. S.
Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma
1997-01-01 Amadori, D; Maltoni, M; Volpi, A; Nanni, O; Scarpi, E; Renault, B; Pellegata, Ns; Gaudio, M; Magni, E; Ranzani, Guglielmina
Genetic events in sporadic colorectal adenomas; K-ras and p53 heterozygous mutations are not sufficient for malignant progression
1993-01-01 De Benedetti, L; Varesco, L; Pellegata, Ns; Losi, L; Gismondi, V; Casarino, L; Sciallero, S; Bonelli, L; Biticchi, R; Bafico, A; Masetti, E; James, R; Heouaine, A; Ranzani, Guglielmina; Aste, H; Ferrara, Gb
Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients
1990-01-01 Ranzani, Guglielmina; Pellegata, Ns; Previderè, C; Saragoni, A; Vio, A; Maltoni, M; Amadori, D.
Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment
2021-01-01 Mohr, H.; Foscarini, A.; Steiger, K.; Ballke, S.; Rischpler, C.; Schilling, F.; Pellegata, N. S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A 5'-truncated c-myc gene variant not associated with a risk of cancer | 1-gen-1991 | Pellegata, Ns; Bergamaschi, G; Amadori, D; Aloia, A; Ballarini, P; Del Senno, L; Amaducci, L; Ranzani, Guglielmina | |
| Adipocyte-specific tribbles pseudokinase 1 regulates plasma adiponectin and plasma lipids in mice | 1-gen-2022 | Ha, E. E.; Quartuccia, G. I.; Ling, R.; Xue, C.; Karikari, R. A.; Hernandez-Ono, A.; Hu, K. Y.; Matias, C. V.; Imam, R.; Cui, J.; Pellegata, N. S.; Herzig, S.; Georgiadi, A.; Soni, R. K.; Bauer, R. C. | |
| Adiponectin affects the mechanical responses in strips from the mouse gastric fundus | 1-gen-2018 | Idrizaj, E.; Garella, R.; Castellini, G.; Mohr, H.; Pellegata, N. S.; Francini, F.; Ricca, V.; Squecco, R.; Baccari, M. C. | |
| Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients | 1-gen-2019 | Daly, A. F.; Rostomyan, L.; Betea, D.; Bonneville, J. -F.; Villa, C.; Pellegata, N. S.; Waser, B.; Reubi, J. -C.; Stephan, C. W.; Christ, E.; Beckers, A. | |
| Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix | 1-gen-1995 | Tenti, P; Romagnoli, S; Silini, E; Pellegata, Ns; Zappatore, Rita; Spinillo, Arsenio; Zara, Carlo; Ranzani, Guglielmina; Carnevali, Luciano | |
| Angpt2/Tie2 autostimulatory loop controls tumorigenesis | 1-gen-2022 | Karabid, N. M.; Wiedemann, T.; Gulde, S.; Mohr, H.; Segaran, R. C.; Geppert, J.; Rohm, M.; Vitale, G.; Gaudenzi, G.; Dicitore, A.; Ankerst, D. P.; Chen, Y.; Braren, R.; Kaissis, G.; Schilling, F.; Schillmaier, M.; Eisenhofer, G.; Herzig, S.; Roncaroli, F.; Honegger, J. B.; Pellegata, N. S. | |
| Animal models of MEN1 | 1-gen-2017 | Mohr, H.; Pellegata, N. S. | |
| Animal models of multiple endocrine neoplasia | 1-gen-2016 | Wiedemann, T.; Pellegata, N. S. | |
| Base transitions are the most frequent genetic changes at P53 in gastric cancer | 1-gen-1993 | Renault, B; van den Broek, M; Fodde, R; Wijnen, J; Pellegata, Ns; Amadori, D; Khan, Pm; Ranzani, Guglielmina | |
| CDKN1B (p27) defects leading to pituitary tumors | 1-gen-2021 | Pellegata, Natalia S. | |
| Characterization of neuroendocrine tumors in heterozygous mutant MENX rats: A novel model of invasive medullary thyroid carcinoma | 1-gen-2018 | Molatore, S.; Kugler, A.; Irmler, M.; Wiedemann, T.; Neff, F.; Feuchtinger, A.; Beckers, J.; Robledo, M.; Roncaroli, F.; Pellegata, N. S. | |
| Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects | 1-gen-2022 | Gulde, Sebastian; Foscarini, Alessia; April-Monn, Simon L.; Genio, Edoardo; Marangelo, Alessandro; Satam, Swapna; Helbling, Daniel; Falconi, Massimo; Toledo, Rodrigo A.; Schrader, Jörg; Perren, Aurel; Marinoni, Ilaria; Pellegata, Natalia S. | |
| Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer | 1-gen-1992 | Pellegata, Ns; Losekoot, M; Fodde, R; Pugliese, V; Saccomanno, S; Renault, B; Bernini, Lf; Ranzani, Guglielmina | |
| Editorial: Stem Cells in Endocrine Tumors | 1-gen-2021 | Di Franco, S.; Pellegata, N. S.; Luconi, M.; Stassi, G. | |
| Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions | 1-gen-2001 | Scovassi, Al; Pellegata, Ns; Di Stefano, L; Padovan, L; Negri, C; Prosperi, Ennio; Riva, Federica; Ciomei, M; Ranzani, Guglielmina | |
| Gender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumors | 1-gen-2021 | Gulde, S.; Wiedemann, T.; Schillmaier, M.; Valenca, I.; Lupp, A.; Steiger, K.; Yen, H. -Y.; Bauerle, S.; Notni, J.; Luque, R.; Schmid, H.; Schulz, S.; Ankerst, D. P.; Schilling, F.; Pellegata, N. S. | |
| Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma | 1-gen-1997 | Amadori, D; Maltoni, M; Volpi, A; Nanni, O; Scarpi, E; Renault, B; Pellegata, Ns; Gaudio, M; Magni, E; Ranzani, Guglielmina | |
| Genetic events in sporadic colorectal adenomas; K-ras and p53 heterozygous mutations are not sufficient for malignant progression | 1-gen-1993 | De Benedetti, L; Varesco, L; Pellegata, Ns; Losi, L; Gismondi, V; Casarino, L; Sciallero, S; Bonelli, L; Biticchi, R; Bafico, A; Masetti, E; James, R; Heouaine, A; Ranzani, Guglielmina; Aste, H; Ferrara, Gb | |
| Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients | 1-gen-1990 | Ranzani, Guglielmina; Pellegata, Ns; Previderè, C; Saragoni, A; Vio, A; Maltoni, M; Amadori, D. | |
| Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment | 1-gen-2021 | Mohr, H.; Foscarini, A.; Steiger, K.; Ballke, S.; Rischpler, C.; Schilling, F.; Pellegata, N. S. |